ONL Therapeutics Announces Multiple Presentations at Leading Ophthalmology Meetings
ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of ...
manilatimes10d
ONL Therapeutics Announces Multiple Presentations at Leading Ophthalmology Meetings
at the Starr Center and Wyndham Boston Beacon Hill Hotel in Boston, Massachusetts Details of the Macula Society Meeting presentation: Title: Fas Inhibition with ONL1204 Ophthalmic Solution for the ...
Business Insider9d
ONL Therapeutics Announces Multiple Presentations at Leading Ophthalmology Meetings
at the Starr Center and Wyndham Boston Beacon Hill Hotel in Boston, Massachusetts About ONL1204 Ophthalmic Solution ONL1204 is a novel, first-in-class small molecule Fas inhibitor designed to ...